NASDAQ · SENS
Senseonics Holdings, Inc.
Healthcare · Medical - Devices
$10.05▲ 0.45% ($0.04)today
As of 9:58 AM ET
Market cap
$419.82M
P/E
-4.43
EPS (TTM)
-$1.89
Next earnings
Nov 4, 2026
Valuation
Revenue & margin DCF
A cash-flow estimate wouldn't be reliable here
More than 85% of this valuation sits in the terminal value beyond year 10, so the result is driven by the perpetuity assumption rather than the projected decade. The valuation is not shown.
- 10-yr revenue CAGR
- 19.6%
- Ending operating margin
- 0.0%
- Discount rate
- 10.5%
USD · TTM ending Jun 30, 2026 · Price used $10.05 · Price Sep 28, 1:58 PM UTC
What each scenario assumes. Click a column to start from it.
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock rose 8.7% over the last year. Revenue grew 90.63% over the trailing twelve months. Operating margin moved from -254.96% to -223.22%. Free cash flow declined 76.71% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at -223.22%. A decisive move in revenue — currently up 90.63% — would be the clearest signal to resolve the ambiguity.
Return analysis
Company profile
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems.
Market multiples
Stock splits
Every 20 shares became 1
Profitability & growth
Analyst consensus
9
Buy
5
Hold
3
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Nov 4, 2026
Q4 FY26 · EPS est -$0.52 · Revenue est $16.2M
View
Institutional Sentiment
Senseonics Holdings, Inc. · SENS
From Form 13F filings (managers with $100M+). Filings land up to 45 days after quarter end — read this as positioning context, not live fund flow.